The global health check-up market size was valued at USD 48.71 billion in 2022 and is expected to grow at a compound annual growth rate (CAGR) of 5.3% from 2023 to 2030. The market growth is attributable to the increasing prevalence of chronic diseases, rising investments from government bodies to establish population medical screening initiatives, and the adoption of telemedicine & home-based services. For instance, in May 2023, the Indian Health Ministry launched a medical screening initiative for people with hypertension and diabetes. This initiative will provide standard care to around 75 million people suffering from non-communicable diseases by 2025.

Moreover, the introduction of telemedicine in general healthcare practices fueled the home-based testing market, while the healthcare ecosystem's digital connectivity framework powered the health check-up market during the COVID-19 pandemic. The increasing prevalence of life-threatening diseases is one of the key drivers for the industry. Additionally, non-communicable diseases such as diabetes, hypertension, cancer, and cardiovascular diseases are increasing, which often remain asymptomatic in the early stages. For instance, as per an AMGA article, more than 30% of the U.S. population suffers from prehypertension, increasing the chances of developing high blood pressure. Regular health check-up allows individuals to manage the condition effectively, as only 1 in 4 U.S. adults have their hypertension under control.

Gather more insights about the market drivers, restrains and growth of the Global health check-up market

Health Check-up Market Segments Highlights:

• The general health check-up segment held the largest share of 36.84% in 2022. General health check-up provides a comprehensive overview of the individual’s health, helping to identify risk factors and manage the health condition at early stages.
• The specialized health check-up segment is expected to show the fastest growth rate during the forecast period. Specialized health check-ups focus on cardiovascular health, cancer screenings, metabolic disorders, or genetic predispositions.
• The blood glucose tests held the largest share of 21.91% in 2022, which can be attributed to the increasing cases of diabetes across the globe.
• The tumor biomarkers segment is expected to register the fastest growth rate during the forecast period. Tumor biomarker tests identify individuals with a higher risk of developing cancer-based on their biomarker profiles, family history, or other risk factors.
• The cardiovascular diseases segment held the largest market share of 28.59% in 2022, attributed to increasing disease prevalence, high mortality rates, and advancement in testing products.
• The cancer segment is expected to grow at the fastest rate during the forecast period. The growth is attributed to the increasing prevalence of cancer across the economies, with high mortality rates in significant countries.
• Hospital-based laboratories dominated the market with a share of 58.10% in 2022. Hospital-based laboratories are equipped with advanced medical equipment and infrastructure for conducting a wide range of diagnostic tests and screenings, thereby providing demand for the segment.
• The standalone laboratories segment is expected to show the fastest growth rate during the forecast period.
• The individuals segment held the largest market share of 68.50% in 2022 attributed to the increasing awareness of general & preventive health benefits amongst the general population.
• The enterprise segment of the market is expected to grow at the fastest rate during the forecast period. Enterprises such as multinational corporations, educational institutions, and government bodies offer health check-ups as an employee wellness benefit to assess the medical status of their employees, identify potential medical risks, and offer appropriate interventions.
• North America dominated the market with a share of 37.30% in 2022, it is due to the increasing healthcare coverage across the region.
• The Asia-Pacific region is expected to grow at the fastest rate during the forecast period. The market growth is due to the increasing government initiatives to improve healthcare services owing to an increased incidence of communicable and non-communicable diseases.

Browse through Grand View Research's Clinical Diagnostics Industry Research Reports.

• Hepatitis Diagnostic Tests Market: The global hepatitis diagnostic tests market size was valued at USD 3.82 billion in 2023 and is projected to grow at a CAGR of 6.5% from 2024 to 2030.
• Breast Cancer Liquid Biopsy Market: The global breast cancer liquid biopsy market size was estimated at USD 1.17 billion in 2024 and is projected to grow at a CAGR of 8.5% from 2025 to 2030.

Health Check-up Market Segmentation

For the purpose of this report, Grand View Research has segmented the global health check-up market based on type, test type, application, service provider, end-use, and region:

Health Check-up Type Outlook (Revenue, USD Million, 2018 - 2030)

• General Health Check-up
• Preventive Health Check-up
• Specialized Health Check-up
• Routine and Wellness Health Check-up

Health Check-up Test Type Outlook (Revenue, USD Million, 2018 - 2030)

• Blood Glucose Test
• Kidney Function Test
• Bone Profile Test
• Electrolyte Test
• Liver Function Test
• Lipid Profile Test
• Special Biochemistry
• Cardiac Biomarkers
• Hormones & Vitamins
• Tumor Markers
• Others

Health Check-up Application Outlook (Revenue, USD Million, 2018 - 2030)

• Cardiovascular Diseases
• Metabolic Disorders
• Cancer
• Inflammatory Conditions
• Musculoskeletal Disorders
• Neurological Conditions
• Others

Health Check-up Service Provider Outlook (Revenue, USD Million, 2018 - 2030)

• Hospital-Based Laboratories
• Central Laboratories
• Standalone Laboratories

Health Check-up End-Use Outlook (Revenue, USD Million, 2018 - 2030)

• Enterprise
• Individuals

Health Check-up Regional Outlook (Revenue, USD Million, 2018 - 2030)

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East and Africa

Order a free sample PDF of the Health Check-up Market Intelligence Study, published by Grand View Research.